Back to MORGAN STANLEY MORGAN STANLEY

ANIKANIK
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ANIKA THERAPEUTICS INC

Yes. Morgan Stanley holds 614,320 shares of ANIK (Anika Therapeutics), worth $9M, as of its Q2 2026 13F filing. It reduced the position by 257,746 shares (-29.6%) from Q1 2026. Morgan Stanley has held ANIK in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$9M

Current Shares

614,320

Total Value Change

-$2.2M

Total Shares Change

+161,343

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
614,320
-29.6%
$9M0.0%$14.63
0
2026-Q1
Increased
872,066
+12.9%
$12.6M0.0%$14.50
32
2025-Q4
Increased
772,230
+95.6%
$7.4M0.0%$9.61
44
2025-Q3
Increased
394,741
+264.2%
$3.7M0.0%$9.40
43
2025-Q2
Decreased
108,382
-13.2%
$1.1M0.0%$10.58
0
2025-Q1
Decreased
124,836
-34.0%
$1.9M0.0%$15.03
0
2024-Q4
Decreased
189,178
-58.2%
$3.1M0.0%$16.46
0
2024-Q3
Decreased
452,977
-9.8%
$11.2M0.0%$24.70
0

Other major holders of ANIK: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used